Marine Biopharmaceutical Market - Global Outlook and Forecast 2023-2028

Report ID: 1366765 | Published Date: Sep 2024 | No. of Page: 102 | Base Year: 2023 | Rating: 4.3 | Webstory: Check our Web story
1 Introduction to Research & Analysis Reports
    1.1 Marine Biopharmaceutical Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Marine Biopharmaceutical Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Marine Biopharmaceutical Overall Market Size
    2.1 Global Marine Biopharmaceutical Market Size: 2021 VS 2028
    2.2 Global Marine Biopharmaceutical Market Size, Prospects & Forecasts: 2017-2028
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Marine Biopharmaceutical Players in Global Market
    3.2 Top Global Marine Biopharmaceutical Companies Ranked by Revenue
    3.3 Global Marine Biopharmaceutical Revenue by Companies
    3.4 Top 3 and Top 5 Marine Biopharmaceutical Companies in Global Market, by Revenue in 2021
    3.5 Global Companies Marine Biopharmaceutical Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Marine Biopharmaceutical Players in Global Market
        3.6.1 List of Global Tier 1 Marine Biopharmaceutical Companies
        3.6.2 List of Global Tier 2 and Tier 3 Marine Biopharmaceutical Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 by Type - Global Marine Biopharmaceutical Market Size Markets, 2021 & 2028
        4.1.2 Drugs
        4.1.3 Health Supplement
    4.2 By Type - Global Marine Biopharmaceutical Revenue & Forecasts
        4.2.1 By Type - Global Marine Biopharmaceutical Revenue, 2017-2022
        4.2.2 By Type - Global Marine Biopharmaceutical Revenue, 2023-2028
        4.2.3 By Type - Global Marine Biopharmaceutical Revenue Market Share, 2017-2028
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Marine Biopharmaceutical Market Size, 2021 & 2028
        5.1.2 Hospital & Clinic
        5.1.3 Pharmacy
        5.1.4 Other
    5.2 By Application - Global Marine Biopharmaceutical Revenue & Forecasts
        5.2.1 By Application - Global Marine Biopharmaceutical Revenue, 2017-2022
        5.2.2 By Application - Global Marine Biopharmaceutical Revenue, 2023-2028
        5.2.3 By Application - Global Marine Biopharmaceutical Revenue Market Share, 2017-2028
6 Sights by Region
    6.1 By Region - Global Marine Biopharmaceutical Market Size, 2021 & 2028
    6.2 By Region - Global Marine Biopharmaceutical Revenue & Forecasts
        6.2.1 By Region - Global Marine Biopharmaceutical Revenue, 2017-2022
        6.2.2 By Region - Global Marine Biopharmaceutical Revenue, 2023-2028
        6.2.3 By Region - Global Marine Biopharmaceutical Revenue Market Share, 2017-2028
    6.3 North America
        6.3.1 By Country - North America Marine Biopharmaceutical Revenue, 2017-2028
        6.3.2 US Marine Biopharmaceutical Market Size, 2017-2028
        6.3.3 Canada Marine Biopharmaceutical Market Size, 2017-2028
        6.3.4 Mexico Marine Biopharmaceutical Market Size, 2017-2028
    6.4 Europe
        6.4.1 By Country - Europe Marine Biopharmaceutical Revenue, 2017-2028
        6.4.2 Germany Marine Biopharmaceutical Market Size, 2017-2028
        6.4.3 France Marine Biopharmaceutical Market Size, 2017-2028
        6.4.4 U.K. Marine Biopharmaceutical Market Size, 2017-2028
        6.4.5 Italy Marine Biopharmaceutical Market Size, 2017-2028
        6.4.6 Russia Marine Biopharmaceutical Market Size, 2017-2028
        6.4.7 Nordic Countries Marine Biopharmaceutical Market Size, 2017-2028
        6.4.8 Benelux Marine Biopharmaceutical Market Size, 2017-2028
    6.5 Asia
        6.5.1 By Region - Asia Marine Biopharmaceutical Revenue, 2017-2028
        6.5.2 China Marine Biopharmaceutical Market Size, 2017-2028
        6.5.3 Japan Marine Biopharmaceutical Market Size, 2017-2028
        6.5.4 South Korea Marine Biopharmaceutical Market Size, 2017-2028
        6.5.5 Southeast Asia Marine Biopharmaceutical Market Size, 2017-2028
        6.5.6 India Marine Biopharmaceutical Market Size, 2017-2028
    6.6 South America
        6.6.1 By Country - South America Marine Biopharmaceutical Revenue, 2017-2028
        6.6.2 Brazil Marine Biopharmaceutical Market Size, 2017-2028
        6.6.3 Argentina Marine Biopharmaceutical Market Size, 2017-2028
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Marine Biopharmaceutical Revenue, 2017-2028
        6.7.2 Turkey Marine Biopharmaceutical Market Size, 2017-2028
        6.7.3 Israel Marine Biopharmaceutical Market Size, 2017-2028
        6.7.4 Saudi Arabia Marine Biopharmaceutical Market Size, 2017-2028
        6.7.5 UAE Marine Biopharmaceutical Market Size, 2017-2028
7 Players Profiles
    7.1 Seattle Genetics
        7.1.1 Seattle Genetics Corporate Summary
        7.1.2 Seattle Genetics Business Overview
        7.1.3 Seattle Genetics Marine Biopharmaceutical Major Product Offerings
        7.1.4 Seattle Genetics Marine Biopharmaceutical Revenue in Global Market (2017-2022)
        7.1.5 Seattle Genetics Key News
    7.2 DSM
        7.2.1 DSM Corporate Summary
        7.2.2 DSM Business Overview
        7.2.3 DSM Marine Biopharmaceutical Major Product Offerings
        7.2.4 DSM Marine Biopharmaceutical Revenue in Global Market (2017-2022)
        7.2.5 DSM Key News
    7.3 Eisai Co
        7.3.1 Eisai Co Corporate Summary
        7.3.2 Eisai Co Business Overview
        7.3.3 Eisai Co Marine Biopharmaceutical Major Product Offerings
        7.3.4 Eisai Co Marine Biopharmaceutical Revenue in Global Market (2017-2022)
        7.3.5 Eisai Co Key News
    7.4 Takeda
        7.4.1 Takeda Corporate Summary
        7.4.2 Takeda Business Overview
        7.4.3 Takeda Marine Biopharmaceutical Major Product Offerings
        7.4.4 Takeda Marine Biopharmaceutical Revenue in Global Market (2017-2022)
        7.4.5 Takeda Key News
    7.5 BASF
        7.5.1 BASF Corporate Summary
        7.5.2 BASF Business Overview
        7.5.3 BASF Marine Biopharmaceutical Major Product Offerings
        7.5.4 BASF Marine Biopharmaceutical Revenue in Global Market (2017-2022)
        7.5.5 BASF Key News
    7.6 Amway
        7.6.1 Amway Corporate Summary
        7.6.2 Amway Business Overview
        7.6.3 Amway Marine Biopharmaceutical Major Product Offerings
        7.6.4 Amway Marine Biopharmaceutical Revenue in Global Market (2017-2022)
        7.6.5 Amway Key News
    7.7 Pfizer
        7.7.1 Pfizer Corporate Summary
        7.7.2 Pfizer Business Overview
        7.7.3 Pfizer Marine Biopharmaceutical Major Product Offerings
        7.7.4 Pfizer Marine Biopharmaceutical Revenue in Global Market (2017-2022)
        7.7.5 Pfizer Key News
    7.8 Pelagia (EPAX)
        7.8.1 Pelagia (EPAX) Corporate Summary
        7.8.2 Pelagia (EPAX) Business Overview
        7.8.3 Pelagia (EPAX) Marine Biopharmaceutical Major Product Offerings
        7.8.4 Pelagia (EPAX) Marine Biopharmaceutical Revenue in Global Market (2017-2022)
        7.8.5 Pelagia (EPAX) Key News
    7.9 Pharma Mar SA
        7.9.1 Pharma Mar SA Corporate Summary
        7.9.2 Pharma Mar SA Business Overview
        7.9.3 Pharma Mar SA Marine Biopharmaceutical Major Product Offerings
        7.9.4 Pharma Mar SA Marine Biopharmaceutical Revenue in Global Market (2017-2022)
        7.9.5 Pharma Mar SA Key News
    7.10 Croda
        7.10.1 Croda Corporate Summary
        7.10.2 Croda Business Overview
        7.10.3 Croda Marine Biopharmaceutical Major Product Offerings
        7.10.4 Croda Marine Biopharmaceutical Revenue in Global Market (2017-2022)
        7.10.5 Croda Key News
    7.11 GNC
        7.11.1 GNC Corporate Summary
        7.11.2 GNC Business Overview
        7.11.3 GNC Marine Biopharmaceutical Major Product Offerings
        7.11.4 GNC Marine Biopharmaceutical Revenue in Global Market (2017-2022)
        7.11.5 GNC Key News
    7.12 GSK
        7.12.1 GSK Corporate Summary
        7.12.2 GSK Business Overview
        7.12.3 GSK Marine Biopharmaceutical Major Product Offerings
        7.12.4 GSK Marine Biopharmaceutical Revenue in Global Market (2017-2022)
        7.12.5 GSK Key News
    7.13 TerSera Therapeutics
        7.13.1 TerSera Therapeutics Corporate Summary
        7.13.2 TerSera Therapeutics Business Overview
        7.13.3 TerSera Therapeutics Marine Biopharmaceutical Major Product Offerings
        7.13.4 TerSera Therapeutics Marine Biopharmaceutical Revenue in Global Market (2017-2022)
        7.13.5 TerSera Therapeutics Key News
    7.14 Nordic Naturals
        7.14.1 Nordic Naturals Corporate Summary
        7.14.2 Nordic Naturals Business Overview
        7.14.3 Nordic Naturals Marine Biopharmaceutical Major Product Offerings
        7.14.4 Nordic Naturals Marine Biopharmaceutical Revenue in Global Market (2017-2022)
        7.14.5 Nordic Naturals Key News
    7.15 Carlson Labs
        7.15.1 Carlson Labs Corporate Summary
        7.15.2 Carlson Labs Business Overview
        7.15.3 Carlson Labs Marine Biopharmaceutical Major Product Offerings
        7.15.4 Carlson Labs Marine Biopharmaceutical Revenue in Global Market (2017-2022)
        7.15.5 Carlson Labs Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer
List of Tables
    Table 1. Marine Biopharmaceutical Market Opportunities & Trends in Global Market
    Table 2. Marine Biopharmaceutical Market Drivers in Global Market
    Table 3. Marine Biopharmaceutical Market Restraints in Global Market
    Table 4. Key Players of Marine Biopharmaceutical in Global Market
    Table 5. Top Marine Biopharmaceutical Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global Marine Biopharmaceutical Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global Marine Biopharmaceutical Revenue Share by Companies, 2017-2022
    Table 8. Global Companies Marine Biopharmaceutical Product Type
    Table 9. List of Global Tier 1 Marine Biopharmaceutical Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Marine Biopharmaceutical Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Marine Biopharmaceutical Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Marine Biopharmaceutical Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - Marine Biopharmaceutical Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global Marine Biopharmaceutical Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - Marine Biopharmaceutical Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - Marine Biopharmaceutical Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global Marine Biopharmaceutical Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global Marine Biopharmaceutical Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global Marine Biopharmaceutical Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America Marine Biopharmaceutical Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America Marine Biopharmaceutical Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe Marine Biopharmaceutical Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe Marine Biopharmaceutical Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia Marine Biopharmaceutical Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia Marine Biopharmaceutical Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America Marine Biopharmaceutical Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America Marine Biopharmaceutical Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa Marine Biopharmaceutical Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa Marine Biopharmaceutical Revenue, (US$, Mn), 2023-2028
    Table 30. Seattle Genetics Corporate Summary
    Table 31. Seattle Genetics Marine Biopharmaceutical Product Offerings
    Table 32. Seattle Genetics Marine Biopharmaceutical Revenue (US$, Mn), (2017-2022)
    Table 33. DSM Corporate Summary
    Table 34. DSM Marine Biopharmaceutical Product Offerings
    Table 35. DSM Marine Biopharmaceutical Revenue (US$, Mn), (2017-2022)
    Table 36. Eisai Co Corporate Summary
    Table 37. Eisai Co Marine Biopharmaceutical Product Offerings
    Table 38. Eisai Co Marine Biopharmaceutical Revenue (US$, Mn), (2017-2022)
    Table 39. Takeda Corporate Summary
    Table 40. Takeda Marine Biopharmaceutical Product Offerings
    Table 41. Takeda Marine Biopharmaceutical Revenue (US$, Mn), (2017-2022)
    Table 42. BASF Corporate Summary
    Table 43. BASF Marine Biopharmaceutical Product Offerings
    Table 44. BASF Marine Biopharmaceutical Revenue (US$, Mn), (2017-2022)
    Table 45. Amway Corporate Summary
    Table 46. Amway Marine Biopharmaceutical Product Offerings
    Table 47. Amway Marine Biopharmaceutical Revenue (US$, Mn), (2017-2022)
    Table 48. Pfizer Corporate Summary
    Table 49. Pfizer Marine Biopharmaceutical Product Offerings
    Table 50. Pfizer Marine Biopharmaceutical Revenue (US$, Mn), (2017-2022)
    Table 51. Pelagia (EPAX) Corporate Summary
    Table 52. Pelagia (EPAX) Marine Biopharmaceutical Product Offerings
    Table 53. Pelagia (EPAX) Marine Biopharmaceutical Revenue (US$, Mn), (2017-2022)
    Table 54. Pharma Mar SA Corporate Summary
    Table 55. Pharma Mar SA Marine Biopharmaceutical Product Offerings
    Table 56. Pharma Mar SA Marine Biopharmaceutical Revenue (US$, Mn), (2017-2022)
    Table 57. Croda Corporate Summary
    Table 58. Croda Marine Biopharmaceutical Product Offerings
    Table 59. Croda Marine Biopharmaceutical Revenue (US$, Mn), (2017-2022)
    Table 60. GNC Corporate Summary
    Table 61. GNC Marine Biopharmaceutical Product Offerings
    Table 62. GNC Marine Biopharmaceutical Revenue (US$, Mn), (2017-2022)
    Table 63. GSK Corporate Summary
    Table 64. GSK Marine Biopharmaceutical Product Offerings
    Table 65. GSK Marine Biopharmaceutical Revenue (US$, Mn), (2017-2022)
    Table 66. TerSera Therapeutics Corporate Summary
    Table 67. TerSera Therapeutics Marine Biopharmaceutical Product Offerings
    Table 68. TerSera Therapeutics Marine Biopharmaceutical Revenue (US$, Mn), (2017-2022)
    Table 69. Nordic Naturals Corporate Summary
    Table 70. Nordic Naturals Marine Biopharmaceutical Product Offerings
    Table 71. Nordic Naturals Marine Biopharmaceutical Revenue (US$, Mn), (2017-2022)
    Table 72. Carlson Labs Corporate Summary
    Table 73. Carlson Labs Marine Biopharmaceutical Product Offerings
    Table 74. Carlson Labs Marine Biopharmaceutical Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. Marine Biopharmaceutical Segment by Type in 2021
    Figure 2. Marine Biopharmaceutical Segment by Application in 2021
    Figure 3. Global Marine Biopharmaceutical Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Marine Biopharmaceutical Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Marine Biopharmaceutical Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Marine Biopharmaceutical Revenue in 2021
    Figure 8. By Type - Global Marine Biopharmaceutical Revenue Market Share, 2017-2028
    Figure 9. By Application - Global Marine Biopharmaceutical Revenue Market Share, 2017-2028
    Figure 10. By Region - Global Marine Biopharmaceutical Revenue Market Share, 2017-2028
    Figure 11. By Country - North America Marine Biopharmaceutical Revenue Market Share, 2017-2028
    Figure 12. US Marine Biopharmaceutical Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada Marine Biopharmaceutical Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico Marine Biopharmaceutical Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe Marine Biopharmaceutical Revenue Market Share, 2017-2028
    Figure 16. Germany Marine Biopharmaceutical Revenue, (US$, Mn), 2017-2028
    Figure 17. France Marine Biopharmaceutical Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. Marine Biopharmaceutical Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy Marine Biopharmaceutical Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia Marine Biopharmaceutical Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries Marine Biopharmaceutical Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux Marine Biopharmaceutical Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia Marine Biopharmaceutical Revenue Market Share, 2017-2028
    Figure 24. China Marine Biopharmaceutical Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan Marine Biopharmaceutical Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea Marine Biopharmaceutical Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia Marine Biopharmaceutical Revenue, (US$, Mn), 2017-2028
    Figure 28. India Marine Biopharmaceutical Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America Marine Biopharmaceutical Revenue Market Share, 2017-2028
    Figure 30. Brazil Marine Biopharmaceutical Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina Marine Biopharmaceutical Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa Marine Biopharmaceutical Revenue Market Share, 2017-2028
    Figure 33. Turkey Marine Biopharmaceutical Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel Marine Biopharmaceutical Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia Marine Biopharmaceutical Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE Marine Biopharmaceutical Revenue, (US$, Mn), 2017-2028
    Figure 37. Seattle Genetics Marine Biopharmaceutical Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. DSM Marine Biopharmaceutical Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. Eisai Co Marine Biopharmaceutical Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. Takeda Marine Biopharmaceutical Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. BASF Marine Biopharmaceutical Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 42. Amway Marine Biopharmaceutical Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 43. Pfizer Marine Biopharmaceutical Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 44. Pelagia (EPAX) Marine Biopharmaceutical Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 45. Pharma Mar SA Marine Biopharmaceutical Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 46. Croda Marine Biopharmaceutical Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 47. GNC Marine Biopharmaceutical Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 48. GSK Marine Biopharmaceutical Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 49. TerSera Therapeutics Marine Biopharmaceutical Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 50. Nordic Naturals Marine Biopharmaceutical Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 51. Carlson Labs Marine Biopharmaceutical Revenue Year Over Year Growth (US$, Mn) & (2017-2022)

Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
102
Frequently Asked Questions
Marine Biopharmaceutical Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Marine Biopharmaceutical Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Marine Biopharmaceutical Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports